Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3

作者: Asli Muvaffak , Qi Pan , Haiyan Yan , Rafael Fernandez , Jongwon Lim

DOI: 10.1158/1541-7786.MCR-13-0642

关键词: KRASCancerSynthetic lethalityCancer cellCell growthLow proteinBiologyKinaseCancer researchProtein kinase A

摘要: … Here, the effect of TBK1 on proliferation in a panel of cancer … of TBK1 activity by knockdown or treatment with TBK1 inhibitors did … of phosphorylated S172 of TBK1 (pTBK1 S172 ). Finally, …

参考文章(36)
Jijia Li, Jingjia Huang, Ji‐Hak Jeong, Sun‐Jin Park, Rui Wei, Jieying Peng, Zhiyong Luo, Yen Ting Chen, Yangbo Feng, Jun‐Li Luo, None, Selective TBK1/IKKi dual inhibitors with anticancer potency International Journal of Cancer. ,vol. 134, pp. 1972- 1980 ,(2014) , 10.1002/IJC.28507
Yuchen Chien, Sungchan Kim, Ron Bumeister, Yueh-Ming Loo, Sung Won Kwon, Cynthia L Johnson, Mirey G Balakireva, Yves Romeo, Levy Kopelovich, Michael Gale, Charles Yeaman, Jacques H Camonis, Yingming Zhao, Michael A White, None, RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival Cell. ,vol. 127, pp. 157- 170 ,(2006) , 10.1016/J.CELL.2006.08.034
Naotaka Ogasawara, Makoto Sasaki, Yukimi Itoh, Kentaro Tokudome, Yoshihiro Kondo, Yoshitsugi Ito, Satoshi Tanida, Takeshi Kamiya, Hiromi Kataoka, Takashi Joh, Kunio Kasugai, Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction Journal of Clinical Biochemistry and Nutrition. ,vol. 48, pp. 154- 160 ,(2011) , 10.3164/JCBN.10-69
Jessica E. Hutti, Rhine R. Shen, Derek W. Abbott, Alicia Y. Zhou, Kam M. Sprott, John M. Asara, William C. Hahn, Lewis C. Cantley, Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation Molecular Cell. ,vol. 34, pp. 461- 472 ,(2009) , 10.1016/J.MOLCEL.2009.04.031
Andrey Loboda, Michael Nebozhyn, Rich Klinghoffer, Jason Frazier, Michael Chastain, William Arthur, Brian Roberts, Theresa Zhang, Melissa Chenard, Brian Haines, Jannik Andersen, Kumiko Nagashima, Cloud Paweletz, Bethany Lynch, Igor Feldman, Hongyue Dai, Pearl Huang, James Watters, A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors. BMC Medical Genomics. ,vol. 3, pp. 26- 26 ,(2010) , 10.1186/1755-8794-3-26
Yi-Hung Ou, Michael Torres, Rosalyn Ram, Etienne Formstecher, Christina Roland, Tzuling Cheng, Rolf Brekken, Ryan Wurz, Andrew Tasker, Tony Polverino, Seng-Lai Tan, Michael A. White, TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation Molecular Cell. ,vol. 41, pp. 458- 470 ,(2011) , 10.1016/J.MOLCEL.2011.01.019
Joel L Pomerantz, David Baltimore, NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase The EMBO Journal. ,vol. 18, pp. 6694- 6704 ,(1999) , 10.1093/EMBOJ/18.23.6694
Kiyohiro Takahasi, Nobuo N Suzuki, Masataka Horiuchi, Mitsuaki Mori, Wakako Suhara, Yasutaka Okabe, Yukiko Fukuhara, Hiroaki Terasawa, Shizuo Akira, Takashi Fujita, Fuyuhiko Inagaki, X-ray crystal structure of IRF-3 and its functional implications. Nature Structural & Molecular Biology. ,vol. 10, pp. 922- 927 ,(2003) , 10.1038/NSB1001
James D. Marion, Charlotte F. Roberts, R. Jason Call, Jonathan L. Forbes, Kristina T. Nelson, J. Ellis Bell, Jessica K. Bell, Mechanism of Endogenous Regulation of the Type I Interferon Response by Suppressor of IκB Kinase ϵ (SIKE), a Novel Substrate of TANK-binding Kinase 1 (TBK1) Journal of Biological Chemistry. ,vol. 288, pp. 18612- 18623 ,(2013) , 10.1074/JBC.M112.440859
R R Shen, W C Hahn, Emerging roles for the non-canonical IKKs in cancer Oncogene. ,vol. 30, pp. 631- 641 ,(2011) , 10.1038/ONC.2010.493